A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice
about
PTRF (polymerase I and transcript-release factor) is tissue-specific and interacts with the BFCOL1 (binding factor of a type-I collagen promoter) zinc-finger transcription factor which binds to the two mouse type-I collagen gene promotersDistant mesenchymal progenitors contribute to skin wound healing and produce collagen: evidence from a murine fetal microchimerism modelExtra-cellular matrix in vascular networksSelective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosisAnimal models of systemic sclerosis: their utility and limitations.Regulation of collagen type I in vascular smooth muscle cells by competition between Nkx2.5 and deltaEF1/ZEB1Cloning and characterization of a transcription factor that binds to the proximal promoters of the two mouse type I collagen genesSeparate cis-acting DNA elements control cell type- and tissue-specific expression of collagen binding molecular chaperone HSP47.Thyroid hormone controls multiple independent programs required for limb development in Xenopus laevis metamorphosis.Diverse developmental programs of Xenopus laevis metamorphosis are inhibited by a dominant negative thyroid hormone receptor.Particle-mediated gene therapy of wounds.Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-{beta}-induced collagen expression in kidney cells.Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing.Ligand-dependent genetic recombination in fibroblasts : a potentially powerful technique for investigating gene function in fibrosisProgression and regression in renal vascular and glomerular fibrosis.An HSV-TK transgenic mouse model to evaluate elimination of fibroblasts for fibrosis therapy.Renal fibrosis is not reduced by blocking transforming growth factor-β signaling in matrix-producing interstitial cells.Mesenchymal-specific deletion of C/EBPβ suppresses pulmonary fibrosis.Insights into the mechanisms of renal fibrosis: is it possible to achieve regression?Mesenchymal deficiency of Notch1 attenuates bleomycin-induced pulmonary fibrosis.Connective tissue growth factor causes EMT-like cell fate changes in vivo and in vitro.Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-gammaCell-cell interactions during remodeling of the intestine at metamorphosis in Xenopus laevisEssential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing.Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice. Role of endothelin.Tunable delivery of siRNA from a biodegradable scaffold to promote angiogenesis in vivo.Recent patents on therapeutic applications of the transcription factor decoy approach.Interplay between bone marrow and liver in the pathogenesis of hepatic fibrosis.Extracellular matrix synthesis in vascular disease: hypertension, and atherosclerosis.CCAAT binding transcription factor binds and regulates human COL1A1 promoter activity in human dermal fibroblasts: demonstration of increased binding in systemic sclerosis fibroblasts.Layer-specific chromatin accessibility landscapes reveal regulatory networks in adult mouse visual cortex.Cell-specific in vivo DNA-protein interactions at the proximal promoters of the pro alpha 1(I) and the pro alpha2(I) collagen genes.BMP-7 opposes TGF-beta1-mediated collagen induction in mouse pulmonary myofibroblasts through Id2.Characterization of an evolutionarily conserved far-upstream enhancer in the human alpha 2(I) collagen (COL1A2) gene.Analysis of transcription of the Col6a1 gene in a specific set of tissues suggests a new variant of enhancer region.Sp1 is required for the early response of alpha2(I) collagen to transforming growth factor-beta1.Activated alveolar epithelial cells initiate fibrosis through secretion of mesenchymal proteins.Targeted and regulable expression of transgenes in hepatic stellate cells and myofibroblasts in culture and in vivo using an adenoviral Cre/loxP system to antagonise hepatic fibrosis.Fibroblast-specific expression of a kinase-deficient type II transforming growth factor beta (TGFbeta) receptor leads to paradoxical activation of TGFbeta signaling pathways with fibrosis in transgenic mice.Tissue-specific expression of promoter regions of the alpha1(VI) collagen gene in cell cultures and transgenic mice.
P2860
Q24532001-CF81BBDD-AA23-4B3B-AB82-10E09B9C2C32Q27322245-0F1E5987-12D0-4457-AE81-1AFF3020AD76Q28261826-332F5395-120A-4770-849F-0D456783FF54Q28275409-805AC387-7303-4C08-9B43-02287AA0B57CQ28390528-06D8F567-3B60-41F6-8067-EF42DCB4B0BEQ28569333-8D3E7E93-E655-4DF7-8C67-2E57C2B56400Q28591386-17098414-28E5-4E9F-9932-FFA8C594530DQ30822683-C808900F-293A-4B17-8003-75E200756A83Q33934028-70703940-8702-4EA8-B641-1CE5A15056FDQ33943799-EE8F102D-3798-4484-B2B5-6A61E12A0E2FQ34156747-2C7CFE95-9843-4E96-9C58-45DC680BB9D8Q34232095-F60C866D-3A0B-4F98-B1C6-DFE0EDF66143Q35569825-905C165B-7CF1-4C93-8E83-D6625438775BQ35748013-A51C8FCC-ACB4-4C45-BDEB-FA44DCEE2485Q35758342-AFEDE86A-A750-44AE-8042-8276ED461E5AQ35791776-C7E70C81-0D30-4819-AC28-F52893DB84B2Q36016743-CAB6B0AD-A50B-4161-8563-D8FBF1091E1AQ36044638-A41A1946-2EE4-4D67-9512-83094DD168FAQ36188436-8E0A374E-D67F-4583-942E-73C57A7DE8CEQ36240624-C5ADC5DF-C1A7-4701-B273-0DDA58192872Q36903759-356FA750-CB9C-4373-9D16-6B91330A3575Q37071874-D8560795-6241-4AC5-A826-1247F2B9E965Q37267388-D1E39B7A-5D6F-49BD-B7FA-1EA77AFD58B2Q37316485-A9D894AD-9317-45B4-B181-23AF17D1765AQ37383608-78460B36-9D04-4723-8292-2D74D7B0ECB9Q37633993-7E13355F-0D40-4608-A697-42C090C51BCCQ37948111-A0F78691-35A3-4851-8BA6-A5EE3EC78ED1Q37992675-E90F8F1C-F71C-4658-95A4-F078EA7170D1Q38182973-59AD5D17-6BCC-480D-A6A2-B44E0E267C81Q38307441-EFC3E21B-10AB-43BB-A431-E10053147B8BQ39005713-2CB634B8-95AE-4291-833C-06342451FB5AQ39720858-71A2FB09-C4CE-4470-A8AC-2F0C1DDBF254Q40380725-04082AB7-98B1-482A-94EC-94E43F51525FQ40816121-068E1B08-61A0-4849-B80F-3DD210725FC2Q40889626-BEB66009-1475-4D32-B088-A6685801BDC7Q41094631-3A14867E-9B2E-42F5-AD7B-FE30A853C189Q41838448-E8C668A7-FF59-4259-84E3-9FF15B211030Q41943203-7C348167-7F7F-450C-B364-3F506828FCEAQ42440126-4137F831-C774-469D-A2DA-252EE887FC48Q42442351-4FC3334E-2317-4BD0-9725-62134CE6C87F
P2860
A potent far-upstream enhancer in the mouse pro alpha 2(I) collagen gene regulates expression of reporter genes in transgenic mice
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
A potent far-upstream enhancer ...... orter genes in transgenic mice
@ast
A potent far-upstream enhancer ...... orter genes in transgenic mice
@en
type
label
A potent far-upstream enhancer ...... orter genes in transgenic mice
@ast
A potent far-upstream enhancer ...... orter genes in transgenic mice
@en
prefLabel
A potent far-upstream enhancer ...... orter genes in transgenic mice
@ast
A potent far-upstream enhancer ...... orter genes in transgenic mice
@en
P2093
P2860
P356
P1476
A potent far-upstream enhancer ...... orter genes in transgenic mice
@en
P2093
B Crombrugghe
G Bou-Gharios
H Eberspaecher
K Niederreither
P2860
P304
P356
10.1083/JCB.134.5.1333
P407
P577
1996-09-01T00:00:00Z